Glen Eagle Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Glen Eagle Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71K	Buy
2021 Q4	–	Sell
2021 Q3	$20.1K	Hold
2021 Q2	$29.1K	Hold
2021 Q1	$21.9K	Hold
2020 Q4	$27.6K	Hold
2020 Q3	$15.1K	Hold
2020 Q2	$13.2K	Hold
2020 Q1	$7.63K	Buy
2019 Q4	$6.7K	Buy